• Home
  • NEW DAY MEDICINE
  • 4 (78) 2025
  • 134 -4 (78) 2025 - Iskandarova I.E., Kenjayev S.R. - IMMUNOLOGICAL CHARACTERISTICS OF MYOCARDIAL INFARCTION IN YOUNG PATIENTS

134 -4 (78) 2025 - Iskandarova I.E., Kenjayev S.R. - IMMUNOLOGICAL CHARACTERISTICS OF MYOCARDIAL INFARCTION IN YOUNG PATIENTS

IMMUNOLOGICAL CHARACTERISTICS OF MYOCARDIAL INFARCTION IN YOUNG PATIENTS

Iskandarova I.E. - Termez branch of the Tashkent Medical Academy Surkhandarya region

Kenjayev S.R. - Republican Scientific Center for Emergency Medical Care Uzbekistan Tashkent

Shamsutdinova M.I. - Republican Scientific Center for Emergency Medical Care Uzbekistan Tashkent

Resume

Myocardial infarction (MI) is traditionally considered a disease of the elderly, but in recent decades its frequency has increased among young patients (under 45 years old). Immune mechanisms play a key role in the pathogenesis of MI, especially in young patients, the atherosclerotic process often has its own peculiarities. Studying the immunological aspects of infarction in this category of patients is important for understanding the pathophysiology of the disease and developing new treatment strategies. Inflammation is the main link in the development of atherosclerosis and myocardial infarction.

Keywords: myocardial infarction, young patients, atherosclerosis, atherosclerotic plaque, acute coronary syndrome, endothelium, immunity.

First page

764

Last page

767

For citation:Iskandarova I.E., Kenjayev S.R., Shamsutdinova M.I. - IMMUNOLOGICAL CHARACTERISTICS OF MYOCARDIAL INFARCTION IN YOUNG PATIENTS//New Day in Medicine 4(78)2025 764-767 https://newdayworldmedicine.com/en/new_day_medicine/4-78-2025

List of References

  1. Константинова Е.В., Балаян Н.М., Шостак Н.А. ИНФАРКТ МИОКАРДА У МОЛОДЫХ: ПРИЧИНЫ И ПРОГНОЗ ЗАБОЛЕВАНИЯ. Клиницист. 2017;11(1):10-15. https://doi.org/10.17650/1818-8338-2016-10-4-10-15.
  2. Шмидт Е.А., Бернс С.А., Осокина А.В. и др. Шкала прогнозирования неблагоприятных исходов у больных инфарктом миокарда с подъемом сегмента ST, подвергшихся неотложному чрескожному коронарному вмешательству. Терапевтический архив 2014;86(4):13–8. [Schmidt E.A., Berns S.A., Osokina A.V. et al. Scale prediction of adverse outcomes in patients with myocardial infarction with ST-segment elevation undergoing emergency percutaneous coronary intervention. Terapevticheskiy arkhiv = Therapeutic Archive 2014;86(4):13– 8. (In Russ.)].
  3. Белая И.Е., Коломиец В.И., Мусаева Э.К. Значимость лабораторных показателей в прогнозировании исходов острого инфаркта миокарда. Клиницист 2017;(1):29–35. [Belaya I.E., Kolomiets V.I., Musaeva E.K. Significance of laboratory parameters in prognosis of outcomes of acute myocardial infarction. Klinitsist = Clinician 2016–2017;(4–1): 29–35. (In Russ.)].
  4. Jamil G., Jamil M., Alkhazraji H. et al. Risk factor assessment of young patients with ST-segment elevation myocardial infarction. Am J Cardiovasc Dis 2013;3(3):170–4. PMID: 23991352
  5. Gupta A., Wang Y., Spertus J.A. et al. Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J Am Coll Cardiol 2014;64(4):337–45. DOI: 10.1016/j.jacc.2014.04.054.
  6. Guo R.W., Yang L.X., Wang H. et al. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factorkappaB-dependent pathway in vascular smooth muscle cells. Regul Pept 2008;147(1–3):37–44. DOI: 10.1016/j.regpep.2007.12.005.
  7. Schonbeck U., Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as anti-inflammatory agents? Circulation 2004; 109(21 Suppl 1):II18–26. DOI: 10.1161/01.CIR.0000129505.34151.23. PMID: 15173059
  8. Doughty M., Mehta R., Bruckman D. et al. Acute myocardial infarction in the young – The University of Michigan experience. Am Heart J 2002;143(1):56– 62. PMID: 11773912.
  9. Yunyun W., Tong L., Yingwu L. et al. Analysis of risk factors of ST-segment elevation myocardial infarction in young patients. BMC Cardiovasc Disord 2014;14:179. DOI: 10.1186/1471-2261- 14-179.

    file

    download